Gahlawat, Aoife Ward http://orcid.org/0000-0001-7854-7207
Witte, Tania
Haarhuis, Lisa
Schott, Sarah http://orcid.org/0000-0002-1714-1147
Article History
Received: 28 April 2021
Revised: 13 July 2022
Accepted: 14 July 2022
First Online: 5 August 2022
Competing interests
: HeiScreen GmbH is a company shared by the University Hospital Heidelberg. SS is a shareholder of Heiscreen and Heiscreen NKY GmbH. TW, AWG and SS have a patent Filing EPO EP19174483.8.
: All participants in the study provided written informed consent. The study was approved by the ethics committee of the University of Heidelberg (S-046/2018, S-266/2011, S-393/2019) in accordance with good clinical practice guidelines, national laws and the Declaration of Helsinki.
: Not applicable.